Home › Funds › PERCEPTIVE ADVISORS LLC › EWTX
PERCEPTIVE ADVISORS LLC position in EWTX
EDGEWISE THERAPEUTICS INC · Health Care
PERCEPTIVE ADVISORS LLC reported holding 4,373,974 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$177.7M, representing 2.82% of its reported portfolio and ranking #10 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed EWTX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PERCEPTIVE ADVISORS LLC's EWTX position evolved
PERCEPTIVE ADVISORS LLC first disclosed a stake in EWTX in Q4 2023 at 555,555 shares (US$6.1M). The position peaked in Q2 2026 at 4,373,974 shares, worth US$177.7M. Across 11 filings, PERCEPTIVE ADVISORS LLC increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 4,373,974 shares valued at US$177.7M — a reduction of -50,000 shares quarter over quarter.. Notable position changes include a 318% increase in Q1 2024 (shares fell 1% over the following quarter), a 81% trim in Q1 2025 (shares fell 40% over the following quarter), a 828% increase in Q2 2025 (shares rose 24% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 555.55K | $6.08M | New |
| Q1 2024 | 2.32M | $42.31M | Add |
| Q2 2024 | 1.86M | $33.43M | Reduce |
| Q3 2024 | 2.33M | $62.20M | Add |
| Q4 2024 | 2.69M | $71.70M | Add |
| Q1 2025 | 500.00K | $11.00M | Reduce |
| Q2 2025 | 4.64M | $60.83M | Add |
| Q3 2025 | 3.80M | $61.57M | Reduce |
| Q4 2025 | 4.46M | $110.62M | Add |
| Q1 2026 | 4.42M | $139.36M | Reduce |
| Q2 2026 | 4.37M | $177.71M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EWTX and 13F data
EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$415.1M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EWTX
- ORBIMED ADVISORS LLC 15.52M sh · $630.52M · Q2 2026
- Paradigm Biocapital Advisors LP 10.22M sh · $415.05M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 8.39M sh · $341.00M · Q2 2026
- Novo Holdings A/S 5.35M sh · $217.37M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 4.73M sh · $192.12M · Q2 2026
- BAKER BROS. ADVISORS LP 3.70M sh · $150.40M · Q2 2026
- Siren, L.L.C. 3.18M sh · $129.39M · Q2 2026
- Cormorant Asset Management, LP 2.51M sh · $101.98M · Q2 2026
- Integral Health Asset Management, LLC 2.00M sh · $81.26M · Q2 2026
- BRAIDWELL LP 2.00M sh · $81.14M · Q2 2026
- MPM BioImpact LLC 1.62M sh · $65.85M · Q2 2026
- First Light Asset Management, LLC 1.10M sh · $44.50M · Q2 2026
More on PERCEPTIVE ADVISORS LLC
FAQ
How long has PERCEPTIVE ADVISORS LLC held EWTX?
PERCEPTIVE ADVISORS LLC has disclosed EWTX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is PERCEPTIVE ADVISORS LLC's current position in EWTX?
As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 4.37M shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $177.71M, representing 2.82% of its reported portfolio and ranking #10.
Has PERCEPTIVE ADVISORS LLC been buying or selling EWTX?
In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC reduced its position in EWTX. The position peaked in Q2 2026 at 4.37M shares.
Which other funds hold EWTX?
Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.